Solutions for the Next Generation of Novel Therapies


AMPEL BioSolutions is the leading biomedical research think tank that creatively addresses clinical development bottlenecks and R&D roadblocks. AMPEL interrogates, analyzes, synthesizes & interprets the world’s biomedical knowledge to provide novel solutions for clinical research questions.

  • Resourceful and dedicated, AMPEL is composed of leading experts in autoimmunity, immunogenicity, inflammation and clinical immunology with extensive research and medical experience to address and resolve obstacles.
  • AMPEL assists nonprofit organizations, pharmaceutical companies, clinical research groups, and others in basic research, translational medicine, preclinical research, drug development and repositioning, and biomarker identification.


Local biomedical company battling lupus on many fronts

Charlottesville Tomorrow¬† - June 3, 2018 A Charlottesville company is helping to lead a global scientific effort to…

read more

NBC 29: New Drug Trail Aims to Help Collect Data to Treat Lupus Patients

CHARLOTTESVILLE, Va. (WVIR) - Aired June 2, 2018 A new clinical drug trial in Charlottesville wants to help…

read more

ImmunArray Enters Partnership with Kindstar Global

ImmunArray, a privately held molecular device company dedicated to the development of novel, blood-based in vitro diagnostic tests,…

read more